MEDPLUS Share Price Target 2050

CAGR-based price projection for Medplus Health Services Limited (MEDPLUS) targeting 2050, derived from official NSE exchange closing prices.

Bear Case (-5.0% CAGR)
Rs 191
2050 Target
Base Case (-24.5% CAGR)
Rs 1
2050 Target
Bull Case (-36.8% CAGR)
Rs 0
2050 Target

Current Market Snapshot

CMP: Rs 654.30
52W High: Rs 953.90
52W Low: Rs 649.30
1Y CAGR: -43.0%
3Y CAGR: -24.5%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 622 Rs 494 Rs 414
2028 Rs 591 Rs 373 Rs 262
2029 Rs 561 Rs 281 Rs 165
2030 Rs 533 Rs 212 Rs 105
2031 Rs 506 Rs 160 Rs 66
2032 Rs 481 Rs 121 Rs 42
2033 Rs 457 Rs 91 Rs 26
2034 Rs 434 Rs 69 Rs 17
2035 Rs 412 Rs 52 Rs 11
2036 Rs 392 Rs 39 Rs 7
2037 Rs 372 Rs 30 Rs 4
2038 Rs 354 Rs 22 Rs 3
2039 Rs 336 Rs 17 Rs 2
2040 Rs 319 Rs 13 Rs 1
2041 Rs 303 Rs 10 Rs 1
2042 Rs 288 Rs 7 Rs 0
2043 Rs 274 Rs 5 Rs 0
2044 Rs 260 Rs 4 Rs 0
2045 Rs 247 Rs 3 Rs 0
2046 Rs 235 Rs 2 Rs 0
2047 Rs 223 Rs 2 Rs 0
2048 Rs 212 Rs 1 Rs 0
2049 Rs 201 Rs 1 Rs 0
2050 Rs 191 Rs 1 Rs 0

Other MEDPLUS Price Targets

2025 2026 2027 2028 2030 2035 2040

Frequently Asked Questions

What is the MEDPLUS share price target for 2050?

Based on historical growth analysis, the MEDPLUS share price target for 2050 ranges from Rs 191 (conservative) to Rs 1 (base case) to Rs 0 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of MEDPLUS?

The current market price of MEDPLUS (Medplus Health Services Limited) is Rs 654.30. The 52-week high is Rs 953.90 and 52-week low is Rs 649.30.

Is MEDPLUS a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for MEDPLUS price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at -5.0% CAGR), Base (-24.5% CAGR), and Bull (optimistic at -36.8% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.